| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090991966 |
| P356 | DOI | 10.1007/S10571-017-0528-7 |
| P698 | PubMed publication ID | 28776199 |
| P2093 | author name string | József Haller | |
| Dóra Zelena | |||
| Subodh Kumar Jain | |||
| Csilla Lea Fazekas | |||
| Diána Balázsfi | |||
| Hanga Réka Horváth | |||
| P2860 | cites work | Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter | Q22254130 |
| Ketamine and other glutamate receptor modulators for depression in adults | Q24186746 | ||
| Molecular cloning and functional characterization of human vesicular glutamate transporter 3. | Q24522650 | ||
| Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. | Q24649430 | ||
| Stress and the general adaptation syndrome | Q24677206 | ||
| Mechanisms of stress in the brain | Q26781233 | ||
| A role for glutamate transporters in the regulation of insulin secretion | Q27329065 | ||
| Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons | Q27863302 | ||
| Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. | Q27863377 | ||
| Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons | Q28207970 | ||
| The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate | Q28208620 | ||
| A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons | Q28208903 | ||
| Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation | Q28307689 | ||
| Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter | Q28569334 | ||
| Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3 | Q28573633 | ||
| Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter | Q28574683 | ||
| Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters | Q28581851 | ||
| An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size | Q28587883 | ||
| Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1) | Q28593091 | ||
| Vesicular glutamate transporter expression level affects synaptic vesicle release probability at hippocampal synapses in culture. | Q44968551 | ||
| Role of ionotropic glutamate receptors in the control of prolactin secretion by other neurotransmitters and neuropeptides at the level of the pituitary | Q45022329 | ||
| Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. | Q45153519 | ||
| Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons | Q45223104 | ||
| Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression | Q45284495 | ||
| Hans Selye and the development of the stress concept. Special reference to gastroduodenal ulcerogenesis. | Q45999132 | ||
| Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. | Q46028477 | ||
| Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse | Q46053391 | ||
| Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects | Q46075909 | ||
| Developmentally regulated expression of VGLUT3 during early post-natal life | Q46719099 | ||
| The ontogenic expressions of multiple vesicular glutamate transporters during postnatal development of rat pineal gland | Q46740457 | ||
| Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain | Q46746316 | ||
| The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone | Q46751646 | ||
| The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug | Q46782301 | ||
| Immunocytochemical localization of metabotropic (mGluR2/3 and mGluR4a) and ionotropic (GluR2/3) glutamate receptors in adrenal medullary ganglion cells | Q46836433 | ||
| Effect of blockade of mGluR5 on stress hormone release and its gene expression in the adrenal gland. | Q46867030 | ||
| The origin of quantal size variation: vesicular glutamate concentration plays a significant role. | Q47297063 | ||
| Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. | Q47313742 | ||
| Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. | Q47633542 | ||
| Metabotropic glutamate receptor-mediated excitation and inhibition of sympathetic preganglionic neurones | Q47782259 | ||
| Monosodium glutamate lesions inhibit the N-methyl-D-aspartate-induced growth hormone but not prolactin release in rats | Q47972993 | ||
| Immobility in the forced swim test is adaptive and does not reflect depression | Q48074450 | ||
| Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors | Q48099473 | ||
| Vesicular Glutamate Transporter Inhibitors: Structurally Modified Brilliant Yellow Analogs | Q48169211 | ||
| Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex. | Q48278709 | ||
| Blockade of TrkB receptors in the nucleus accumbens prior to heterotypic stress alters corticotropin-releasing hormone (CRH), vesicular glutamate transporter 2 (vGluT2) and glucocorticoid receptor (GR) within the mesolimbic pathway | Q48282474 | ||
| Stress update Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress | Q48321434 | ||
| Vesicular glutamate transporter 2 is required for central respiratory rhythm generation but not for locomotor central pattern generation. | Q48361312 | ||
| The vesicular glutamate transporter VGLUT3 contributes to protection against neonatal hypoxic stress. | Q48409993 | ||
| Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus | Q48433526 | ||
| Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors | Q48469906 | ||
| Differential contribution of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the intermediolateral cell column of the thoracic spinal cord to sympathetic vasomotor tone during experimental endotoxemia in the rat. | Q48662385 | ||
| NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. | Q51572162 | ||
| Walter Bradford Cannon | Q56059146 | ||
| A Specific Sympathomimetic Ergone in Adrenergic Nerve Fibres (Sympathin) and its Relations to Adrenaline and Nor-Adrenaline | Q56687597 | ||
| The one hundred percent hypothesis: glutamate or GABA in synapses on sympathetic preganglionic neurons | Q72204144 | ||
| Effect of excitatory amino acid receptor agonists on secretion of growth hormone as assessed by the reverse hemolytic plaque assay | Q72829163 | ||
| Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain | Q73447770 | ||
| VGLUT1 and VGLUT2 innervation in autonomic regions of intact and transected rat spinal cord | Q80480605 | ||
| Plasma membrane and vesicular glutamate transporter expression in chromaffin cells of bovine adrenal medulla | Q82289565 | ||
| Glutamate transmission in the rostral ventrolateral medullary sympathetic premotor pathway | Q44599296 | ||
| Expression and functional properties of group I metabotropic glutamate receptors in bovine chromaffin cells | Q44713197 | ||
| Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2) | Q28596575 | ||
| Antidepressant effects of ketamine in depressed patients | Q29617327 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons | Q30308690 | ||
| Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla | Q30308693 | ||
| Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease | Q30383888 | ||
| Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors | Q33605530 | ||
| A population of glomerular glutamatergic neurons controls sensory information transfer in the mouse olfactory bulb | Q33639998 | ||
| Corticotropin-releasing hormone receptor subtypes and emotion | Q33795291 | ||
| l-glutamate as a central neurotransmitter: looking back | Q33915450 | ||
| VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety | Q34098092 | ||
| VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate | Q34315492 | ||
| Regulation of pituitary ACTH secretion during chronic stress | Q34321289 | ||
| Transporters in the neurohypophysial neuroendocrine system, with special reference to vesicular glutamate transporters (BNPI and DNPI): a review | Q34505712 | ||
| Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system | Q34584131 | ||
| Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning | Q34609558 | ||
| Comparison of stress-induced changes in adults and pups: is aldosterone the main adrenocortical stress hormone during the perinatal period in rats? | Q34988344 | ||
| The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow | Q35030872 | ||
| Glutamatergic drive of the dorsal raphe nucleus | Q35148291 | ||
| Distribution of vesicular glutamate transporters in the human brain | Q35149796 | ||
| Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress | Q35381067 | ||
| A single infusion of ketamine improves depression scores in patients with anxious bipolar depression | Q35607157 | ||
| Mild dehydration, vasopressin and the kidney: animal and human studies | Q35610078 | ||
| Vesicular glutamate transporters in the brain | Q35611754 | ||
| Glutamate co-transmission as an emerging concept in monoamine neuron function | Q35712261 | ||
| Glutamate and anxiety | Q35729382 | ||
| An excitatory amacrine cell detects object motion and provides feature-selective input to ganglion cells in the mouse retina | Q35741911 | ||
| Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration | Q35829254 | ||
| Glutamate as a therapeutic target in psychiatric disorders | Q35847653 | ||
| Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin | Q36268474 | ||
| Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications | Q36358110 | ||
| Neurodevelopmental role for VGLUT2 in pyramidal neuron plasticity, dendritic refinement, and in spatial learning | Q36410605 | ||
| Acute regulation of sodium-dependent glutamate transporters: a focus on constitutive and regulated trafficking | Q36487968 | ||
| VGLUTs: 'exciting' times for glutamatergic research? | Q36502195 | ||
| Functional significance of co-localization of GABA and Glu in nerve terminals: a hypothesis | Q36513014 | ||
| Axonal Segregation and Role of the Vesicular Glutamate Transporter VGLUT3 in Serotonin Neurons | Q36789912 | ||
| Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders | Q37143117 | ||
| The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders | Q37172873 | ||
| Novel aspects of glutamatergic signalling in the neuroendocrine system | Q37207345 | ||
| Catecholaminergic systems in stress: structural and molecular genetic approaches. | Q37431126 | ||
| Genetic inactivation of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: what have we learnt about functional glutamatergic neurotransmission? | Q37699410 | ||
| Distinct glutamatergic and GABAergic subsets of hypothalamic pro-opiomelanocortin neurons revealed by in situ hybridization in male rats and mice | Q37730934 | ||
| From glutamate co-release to vesicular synergy: vesicular glutamate transporters | Q37854416 | ||
| New perspectives in glutamate and anxiety. | Q37875262 | ||
| Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport | Q37879648 | ||
| Vesicular and plasma membrane transporters for neurotransmitters | Q37971367 | ||
| Glutamate-based anxiolytic ligands in clinical trials | Q38110306 | ||
| Stress, the stress system and the role of glucocorticoids | Q38250180 | ||
| Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice. | Q38332302 | ||
| Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment | Q38425466 | ||
| Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. | Q38566515 | ||
| Vesicular glutamate transporters as anion channels? | Q38636160 | ||
| Pharmacoendocrinology of major depression | Q38679851 | ||
| Targeting glutamate signalling in depression: progress and prospects | Q38743867 | ||
| Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies | Q38787388 | ||
| Do the distinct synaptic properties of VGLUTs shape pain? | Q38834686 | ||
| Ascending mechanisms of stress integration: Implications for brainstem regulation of neuroendocrine and behavioral stress responses. | Q38840579 | ||
| Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles | Q38896987 | ||
| Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder | Q39070352 | ||
| Cholinergic/glutamatergic co-transmission in striatal cholinergic interneurons: new mechanisms regulating striatal computation | Q39250067 | ||
| The prepulse inhibition deficit appearance is largely independent on the circadian cycle, body weight, and the gender of vasopressin deficient Brattleboro rat. | Q39454380 | ||
| Putative transmitter systems of mammalian sympathetic preganglionic neurons. | Q40710770 | ||
| The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. | Q40769813 | ||
| The innervation of the mammalian adrenal gland. | Q40810804 | ||
| An unconventional glutamatergic circuit in the retina formed by vGluT3 amacrine cells | Q41926066 | ||
| Effect of glutamate receptor agonists on catecholamine secretion in bovine chromaffin cells. | Q42456804 | ||
| Sex-dependent role of vesicular glutamate transporter 3 in stress-regulation and related anxiety phenotype during the early postnatal period. | Q42496618 | ||
| Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. | Q43021300 | ||
| Demonstration of vesicular glutamate transporter-1 in corticotroph cells in the anterior pituitary of the rat. | Q43212823 | ||
| Co-release of glutamate and GABA from single vesicles in GABAergic neurons exogenously expressing VGLUT3. | Q43238422 | ||
| Vesicular glutamate transporter expression in supraoptic neurones suggests a glutamatergic phenotype | Q43251033 | ||
| Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia | Q43258935 | ||
| Gene expression of NMDA receptor subunits in rat adrenals under basal and stress conditions | Q43850659 | ||
| Constitutive expression of heterologous N-methyl-D-aspartate receptor subunits in rat adrenal medulla | Q43947436 | ||
| Molecular mechanisms of glutamate release by bovine chromaffin cells in primary culture | Q44306472 | ||
| Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum | Q44489170 | ||
| P921 | main subject | knockout mouse | Q1364740 |
| P577 | publication date | 2017-08-03 | |
| P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
| P1476 | title | Contribution of Vesicular Glutamate Transporters to Stress Response and Related Psychopathologies: Studies in VGluT3 Knockout Mice |
| Q49490449 | Significance of the Stress Research: "In Memoriam, Richard Kvetnansky". | cites work | P2860 |
Search more.